[Variations in the urinary level of MHPG in depressive syndromes].
MPHG urinary changes were investigated in a group of patients affected by different forms of depressive illness. No significant difference was noticed depending on age, diagnosis, number and duration of episodes. Considering the group as a whole, a significant increase of MHPG urinary levels was noted after the recovery, although the patients received different drugs (Tricyclic + phenothiazine, Trazodone, IMAO). Specifically, the patients treated with IMAO and Trazodone, either recovered or ameliorated, showed a remarkable increase of MHPG urinary levels, whereas a decrease was noticed in the group who was administered tricyclic antidepressants.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001007:Anxiety; D003863:Depression / Q000652:urine*; D003866:Depressive Disorder / Q000652:urine*; D003865:Major Depressive Disorder / Q000652:urine*; D005260:Female; D006018:Glycols / Q000652:urine*; D006801:Humans; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000652:urine*; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010546:Perphenazine / Q000627:therapeutic use; D012008:Recurrence; D014196:Trazodone / Q000627:therapeutic use; D014745:Viloxazine / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D006018:Glycols; D008996:Monoamine Oxidase Inhibitors; D008734:Methoxyhydroxyphenylglycol; D014745:Viloxazine; D010546:Perphenazine; D014196:Trazodone
Variazioni del livello urinario dell'MHPG nelle sindromi depressive.